Have you or a loved one experienced dangerous side effects such as ketoacidosis after taking Invokamet®? Invokamet and other Type 2 diabetes medications which include canagloflozin as their active ingredient have been linked to ketoacidosis, a potentially deadly condition.
The Hollis Law Firm can review your case and help you navigate your options in regards to an Invokamet lawsuit.
Invokamet and Invokana both contain canagliflozin as their active ingredient and are in the class of drugs known as SGLT2 inhibitors, though Invokamet also includes metformin. Invokamet and other SGLT2 inhibitors are prescribed to help treat Type 2 diabetes by preventing glucose from being reabsorbed into the blood. SGLT2 inhibitors block the kidneys from reabsorbing sugar, and instead they secrete it; the glucose then exits the body through urination.
The FDA issued a warning in May of 2015 that Invokamet, Invokana, and other SGLT2 inhibitors may lead to diabetic ketoacidosis, a potentially fatal condition. Testing for ketoacidosis includes ketone testing of blood or urine samples, potassium blood tests, glucose blood tests, arterial blood gas tests, or amylase blood tests. The FDA received approximately 20 reports of patients who were treated with SGLT2 inhibitors between March 2013 and June 2014, and subsequently developed ketoacidosis. All of the reported patients required treatment in a hospital. Treatments for ketoacidosis can include fluid therapy, insulin therapy, and electrolyte therapy.
If you or a loved one were diagnosed with ketoacidosis after taking Invokamet, it may be helpful to know your legal rights. The lawyers at the Hollis Law Firm are available to review your case and answer any questions you may have regarding Invokamet lawsuits. The Hollis Law Firm is located in a suburb of Kansas City and represents clients in Kansas and Missouri, and partners with attorneys in other states to provide representation to clients throughout the United States. Call 1-800-701-3672 for a free Invokana lawsuit review.
